System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Christine Chiaverini is an expert in Dermatology at Centre Hospitalier Universitaire de Nice (France). As of October 2026, ScienceLeadR ranks Christine Chiaverini in the top 1% of experts worldwide for Skin Abnormalities, Congenital Abnormalities and Skin Diseases, Vesiculobullous. Christine Chiaverini has authored 265 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 7 of them ongoing. SLR score: 859 (community average: 125). How the SLR is computed.

LeadR Profile

Christine Chiaverini Centre Hospitalier Universitaire de Nice France
859 ScienceLeadR Reputation 859

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Pediatrics - Genetics - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1999 - 2026
Source: PubMed

Hôpital l'Archet

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 265

Citations

Citations: 3 389 1st author: 27 Last author: 23 Unique author: 10

Main journals

Ann Dermatol Venereol 81
Br J Dermatol 30
J Eur Acad Dermatol Venereol 19
Annales de Dermatologie et de Vénéréologie - FMC 12
Annales de dermatologie et de vénéréologie, FMC 12

Best Journals

Lancet Infect Dis 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Correction: Effectiveness and Safety of IL‑17A Inhibitors in Pediatric Psoriasis: A Real‑World, Multicenter, International Study.
PMID 42870136 — safety, pharmaceutical preparations, psoriasis		Paediatr Drugs20260
Pediatric Phthiriasis Palpebrarum: A French Multicentric Retrospective Study of 20 Cases.
PMID 42437072 — eyelids, retrospective studies, diagnosis, therapeutics, pediatrics, child abuse, child		J Pediatr Clin Pract20261
National qualitative study in France to explore parents' lived experience at the birth of a child with a large or giant congenital melanocytic nevus.
PMID 42419891 — parturition, nevus, pigmented, nevus, child		BMJ Open20260
Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe Cohort.
PMID 42409581 — skin diseases, cyclosporine, adolescent, therapeutics, psoriasis, acitretin, dermatology, methotrexate, child		Pediatr Dermatol20260
Real-World Systemic Treatment Patterns and Outcomes of Children With Severe Alopecia Areata: A French Nationwide Study (ESTAPED ohort).
PMID 42348162 — dermatitis, alopecia areata, pharmaceutical preparations, adrenal cortex hormones, maintenance, therapeutics, methotrexate, child, alopecia, dermatitis, atopic		Paediatr Drugs20260

Clinical Studies 20

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 9

By phase:

N/A 10
Phase 2 7
Phase 3 2
Phase 2/Phase 3 1

By status:

Recruiting 10
Completed 6
Unknown 2
Not yet recruiting 1
Withdrawn 1

By type:

Interventional 15
Observational 5

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 9
multicentric5to9 2
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Treatment of Dysphagia in Patients With Dystrophic Epidermolysis Bullosa With Budesonide a Retrospective Bicentric Study Nice Paris St Louis Necker (EBUDE Study)
NCT07684105 — esophageal stenosis, skin, constriction, pathologic, epidermolysis bullosa dystrophica, esophagus, epidermolysis bullosa, therapeutics, deglutition disorders, mucous membrane, deglutition, wounds and injuries, membranes, budesonide, genetic diseases, inborn		N/ANot yet recruiting2026
Digestive Evolution of Children With Crohn s Disease or Ulcerative Colitis Whose Anti TNF Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis
NCT07529236 — skin, ustekinumab, colitis, crohn disease, inflammatory bowel diseases, therapeutics, psoriasis, colitis, ulcerative, child		N/ARecruiting2026
EBUL0 A 20 Week Multicentre Open Study Assessing the Efficacy and Safety of Apremilast in Patients 6 years of age with Epidermolysis bullosa simplex generalized
2023-508794-83-00 — safety, epidermolysis bullosa simplex, epidermolysis bullosa		Phase 2Recruiting2025
GENEPID A 44 weeks monocentric open study assessing the efficacy and safety of Deucravacitinib in adults with Inflammatory EPidermal GENodermatoses
2022-502879-32-00 — safety, epidermolysis bullosa simplex, epidermolysis bullosa, ichthyosis		Phase 2Recruiting2024
CongenItal Naevus Cohort for Longitudinal Evaluation
NCT06828822 — skin, quality of life, parturition, melanoma, brain, neurodevelopmental disorders, therapeutics, nevus, child, neurodevelopment		N/ARecruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS